Rocket Pharmaceuticals, Inc. Common Stock

RCKTNASDAQ • USD
2.28 USD
↘ 0.02 (0.83%)🟢PRE MARKET (AS OF 03:59 AM EST)
🟢Market: OPEN

Rocket Pharmaceuticals, Inc. Common Stock (RCKT) trades at $2.28 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 13, 2026.

Open?$2.28
High?$2.28
Low?$2.28
Prev. Close?$2.30
Volume?0
Avg. Volume?1.9M
Bid / Ask
Bid?$1.96 × 100
Ask?$2.65 × 100
Spread?$0.69
Midpoint?$2.30
Valuation & Ratios
Market Cap?256.8M
Shares Out?109.8M
Float?84.6M
Float %?77.5%
P/E Ratio?N/A
P/B Ratio?0.79
EPS?-$0.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Employees
202
Market Cap
256.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-02-18
Address
350 FIFTH AVENUE
NEW YORK, NY 10118
Phone: 646-440-9100
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
45
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.87Distress
Confidence?59%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?19.20%High
Short Interest?16.2M
Days to Cover?9.1
Free Float84.6M
Avg Daily Volume1.8M
Settlement Date2026-10-30
Financial Health
Current Ratio?7.26Strong
Quick Ratio?7.25Strong
Cash Ratio?2.49Strong
Debt/Equity?0.16Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.79CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
11
-4.9%WEAK▾
ROA?
S&P
3
-3.9%WEAK▾
Cash Flow & Enterprise
FCF?$-159230000
Enterprise Value?$213.0M
Fundamentals ratios updated end of day